UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Cell reports (Cambridge), 2022-05, Vol.39 (7), p.110829-110829, Article 110829

2022

Link zum Volltext

Verfügbarkeit prüfen

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome

eLife, 2021-04, Vol.10

2021

Link zum Volltext

Verfügbarkeit prüfen

Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth

Cancer research (Chicago, Ill.), 2021-10, Vol.81 (20), p.5336-5352

2021

Link zum Volltext

Verfügbarkeit prüfen

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses

Vaccine, 2014-05, Vol.32 (21), p.2406-2412

2014

Link zum Volltext

Verfügbarkeit prüfen

Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008736-e1008736

2020

Link zum Volltext

Verfügbarkeit prüfen

Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms

Journal of Virology, 2014-01, Vol.88 (1), p.72-81

2014

Link zum Volltext

Verfügbarkeit prüfen

Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids

Journal of virology, 2017-04, Vol.91 (8)

2017

Link zum Volltext

Verfügbarkeit prüfen

A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice

Vaccine, 2014-07, Vol.32 (34), p.4296-4303

2014

Link zum Volltext

Verfügbarkeit prüfen

Blocking LAIR1 signaling in immune cells inhibits tumor development

Frontiers in immunology, 2022-09, Vol.13, p.996026-996026

2022

Link zum Volltext

Verfügbarkeit prüfen

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005454-e1005454

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection

PLoS pathogens, 2019-07, Vol.15 (7), p.e1007914-e1007914

2019

Link zum Volltext

Verfügbarkeit prüfen

Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection

Vaccine, 2013-04, Vol.31 (18), p.2215-2221

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71

Journal of virological methods, 2012-12, Vol.186 (1-2), p.193-197

2012

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine

npj vaccines, 2024-04, Vol.9 (1), p.70-70

2024

Link zum Volltext

Verfügbarkeit prüfen

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV

Emerging microbes & infections, 2023-12, Vol.12 (2), p.2275598-2275598

2023

Link zum Volltext

Verfügbarkeit prüfen

Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor

Emerging microbes & infections, 2017, Vol.6 (1), p.1-7

2017

Link zum Volltext

Verfügbarkeit prüfen

Detection, characterization and quantitation of Coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins

Journal of virological methods, 2011-04, Vol.173 (1), p.115-120

2011

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in development of monoclonal antibodies against human cytomegalovirus

Current opinion in virology, 2022-02, Vol.52, p.166-173

2022

Link zum Volltext

Verfügbarkeit prüfen

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2022-05, Vol.36 (3), p.231-323

2022

Link zum Volltext

Verfügbarkeit prüfen

Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry

Journal of virology, 2015-12, Vol.89 (23), p.12084-12095

2015

Link zum Volltext

Verfügbarkeit prüfen

Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor

Cell metabolism, 2022-04, Vol.34 (4), p.549-563.e8

2022

Link zum Volltext

Verfügbarkeit prüfen

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

Nature chemical biology, 2023-03, Vol.19 (3), p.284

2023

Link zum Volltext

Verfügbarkeit prüfen

High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice

Vaccine, 2015-05, Vol.33 (20), p.2335-2341

2015

Link zum Volltext

Verfügbarkeit prüfen

Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice

Antiviral research, 2016-05, Vol.129, p.47-51

2016

Link zum Volltext

Verfügbarkeit prüfen

Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge

Vaccine, 2016-09, Vol.34 (41), p.5005-5012

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionAPS Digital Backfile Archive (DFG Nationallizenzen)

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome

Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth

A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses

Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step

Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms

Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids

A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice

Blocking LAIR1 signaling in immune cells inhibits tumor development

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody

Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection

Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection

Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71

Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV

Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor

Detection, characterization and quantitation of Coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins

Recent progress in development of monoclonal antibodies against human cytomegalovirus

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry

Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice

Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice

Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge

Aktive Filter

Suchergebnisse filtern